Method Of Identifying Inhibitors Of The Jak-STAT Signal Transduction Pathway

Description:
The invention provides identification methods for agents which inhibit the Jak-STAT signaling transduction pathway. Drugs identified by these methods are candidates for the treatment of proliferative disorders dependent on the Jak-STAT pathway, including those caused by HTLV-1. In addition, such agents may be potent immunosuppressive drugs with potential applications not only for organ transplantation but also for treatment of autoimmune diseases.
Patent Information:
For Information, Contact:
Michael Shmilovich
Senior Licensing And Patenting Manager
NIH Technology Transfer
301-435-5019
shmilovm@nih.gov
Inventors:
Warren Leonard
Keywords:
HTLV-1
HTLV-2
HTLV-3
Human T Cell Leukemia Virus 1
Human T-cell leukemia viruses type 2
Human T-lymphotropic virus type 3
IBXXXX
ICXXXX
IXXXXX
© 2024. All Rights Reserved. Powered by Inteum